Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


ABScumplotTwo landmark studies, carried out in conjunction with NHS England, have examined the long-term outcomes following ductal carcinoma in situ (DCIS), which is the commonest form of pre-invasive breast cancer.   

The first one examined data on 35,000 women whose DCIS was detected via the NHS breast screening programme.  It showed that the risk of dying from breast cancer was similar to that for women in the general population for about five years after diagnosis of DCIS.  But, after that, the risk increased and the 20-year risk of death from breast cancer was twice that of women in the general population.  

The second study looked at data on 27,000 women whose disease was not screen-detected and showed that the risk of mortality from breast cancer were even higher. 

These studies have important implications for the management of patients with DCIS in the future. 

Office for National Statistics logo  This study was awarded the 2020 Office for National Statistics Research Excellence prize.


Back to Benefits and Risks of Cancer Treatments home page